Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.44 |
| ▸ | ADH1A | P07327 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | ADH7 | P40394 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24672303 | 0.94 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL277270 | 0.91 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4660468 | 0.88 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4603730 | 0.88 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14142731 | 0.88 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL23902076 | 0.88 | ADH1B (0.41) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL16223598 | 0.88 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL570864 | 0.88 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL12201612 | 0.88 | ADH1B (0.41) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL10952637 | 0.88 | ADH1B (0.41) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3165561-B1 | RAPID CURING THIOL EPOXY RESIN WITH IMPROVED COMPRESSION STRENGTH PERFORMANCE | BOEING CO (US) | 2021-01-13 | — | — | EP | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-110590844-A | Preparation method for synthesizing tenofovir alafenamide by two-step method | 江西农业大学 | 2019-12-20 | — | — | CN | claimed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | claimed |
| EP-2980093-B1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2019-01-09 | — | — | EP | claimed |
| EP-2980092-B1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2017-10-04 | — | — | EP | claimed |
| EP-2601201-B1 | PROCESS FOR PREPARATION OF NOVEL 42-0-(HETEROALKOXYALKYL) RAPAMYCIN COMPOUNDS WITH ANTI-PROLIFERATIVE PROPERTIES\ | MERIL LIFE SCIENCES PVT LTD (IN) | 2014-09-24 | — | — | EP | claimed |
| EP-1511689-B1 | SYNTHESIS OF SILICOALUMINOPHOSPHATES | EXXONMOBIL CHEM PATENTS INC (US) | 2005-12-07 | — | — | EP | claimed |
| US-4658005-A | Storage-stabile polyurethane resin powder enamels or varnishes | HULS AKTIENGESELLSCHAFT (DE) | 1987-04-14 | — | — | US | claimed |
| US-12428383-B2 | Gas-phase process for the conversion of glycolaldehyde with an aminating agent | BASF SE (DE) | 2025-09-30 | — | — | US | disclosed |
| US-12162842-B2 | Conversion of glycolaldehyde with an aminating agent | BASF SE (DE) | 2024-12-10 | — | — | US | disclosed |
| CN-113993837-B | Vapor phase process for converting glycolaldehyde with amination agent | 巴斯夫欧洲公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-113950469-B | Conversion of glycolaldehyde with an amination agent | 巴斯夫欧洲公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-111971269-B | Reaction of glycolaldehyde | 塔明克私人有限公司 | 2024-02-13 | — | — | CN | disclosed |
| US-4468526-A | Process for the preparation of thiuram disulfides | AKZONA INCORPORATED (US) | 1984-08-28 | — | — | US | disclosed |
| US-4459424-A | SECONDARY AMINE, CARBON DISULFIDE, METAL CONTAINING CATALYST | AKZONA INCORPORATED (US) | 1984-07-10 | — | — | US | disclosed |
| US-4430513-A | COBALT OR RHODIUM CARBONYL, CARBON-CARBON BOND FORMATION | UOP INC. (US) | 1984-02-07 | — | — | US | disclosed |
| US-4029734-A | ROASTING WITH SULFURIC ACID AND AN OXIDANT | UOP INC. (US) | 1977-06-14 | — | — | US | disclosed |
| US-3992349-A | Photodegradable polyolefin composition containing a mixture of an aryl ketone and an alkanolamine | UOP INC. (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162842-B2 | Conversion of glycolaldehyde with an aminating agent | ADH1A, ALDOA, ADH5 | ADH1B 49/4885ADH1C 8/4885ADH1A 1/4885 |
| US-12428383-B2 | Gas-phase process for the conversion of glycolaldehyde with an aminating agent | HDHD5, ADH5, UGCG | ADH1B 431/4885ADH1C 22/4885ADH1A 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.